Literature DB >> 30505648

Medical Management of Vascular Anomalies.

Reema Padia1, Randall Bly1, Catherine Bull1, Amy E Geddis2, Jonathan Perkins1.   

Abstract

PURPOSE OF REVIEW: This chapter will summarize the most recent literature regarding the current state of medical treatment for vascular anomalies. RECENT
FINDINGS: Research into the biology of these anomalies has strengthened our understanding of each anomaly and has helped to pave the way for more tailored treatment options involving molecular and/or genetic targets.
SUMMARY: While there is still a role for surgical intervention, medical therapies that target the etiology of vascular anomalies may represent an alternative or adjunctive approach in the management of these lesions.

Entities:  

Keywords:  Infantile hemangioma; genetics; lymphatic malformation; propranolol; rapamycin; vascular anomalies

Year:  2018        PMID: 30505648      PMCID: PMC6261360          DOI: 10.1007/s40746-018-0130-3

Source DB:  PubMed          Journal:  Curr Treat Options Pediatr        ISSN: 2198-6088


  89 in total

Review 1.  Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature.

Authors:  Dawn H Siegel; Kimberly A Tefft; Teresa Kelly; Craig Johnson; Denise Metry; Patricia Burrows; Elena Pope; Maria Cordisco; Kristen E Holland; Mohit Maheshwari; Phillip Keith; Maria Garzon; Christopher Hess; Ilona J Frieden; Heather J Fullerton; Beth A Drolet
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

2.  Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.

Authors:  M Snir; U Reich; R Siegel; A Zvulunov; R Friling; N Goldenberg-Cohen; Y Ron; D Ben-Amitay
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

3.  Oral propranolol: an effective, safe treatment for infantile hemangiomas.

Authors:  Hesham Zaher; Hoda Rasheed; Rehab A Hegazy; Ranya A Hegazy; Dalia M Abdelhalim; Heba I Gawdat
Journal:  Eur J Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.328

Review 4.  Head and neck lymphatic malformation treatment: a systematic review.

Authors:  Mary Theresa Adams; Babette Saltzman; Jonathan A Perkins
Journal:  Otolaryngol Head Neck Surg       Date:  2012-07-11       Impact factor: 3.497

5.  Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations.

Authors:  Karthik Balakrishnan; Maithilee D Menezes; Brian S Chen; Anthony E Magit; Jonathan A Perkins
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-01       Impact factor: 6.223

6.  Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures.

Authors:  Jonathan A Perkins; Brian S Chen; Babette Saltzman; Scott C Manning; Sanjay R Parikh
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-03       Impact factor: 6.223

7.  Predicting complications with pretreatment testing in infantile haemangioma treated with oral propranolol.

Authors:  Lilian Yh Tang; Jeremy Wg Hing; Jasmine Ym Tang; Hiroshi Nishikawa; Hossain Shahidullah; Fiona Browne; Ashish Chikermane; Manoj Parulekar
Journal:  Br J Ophthalmol       Date:  2015-10-26       Impact factor: 4.638

8.  Diagnosis and surgical treatment of cervical macrocystic lymphatic malformations in infants.

Authors:  Jing Ma; Ruan Biao; Fan Lou; Ken Lin; Ying-Qin Gao; Mei-Lan Wang; Yan-Li Yang; Tie-Song Zhang
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

9.  Management of Orbital and Periorbital Venous Malformation.

Authors:  Lara A Benoiton; Kenneth Chan; Frederica Steiner; Trevor FitzJohn; Swee T Tan
Journal:  Front Surg       Date:  2017-05-29

10.  Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.

Authors:  Lara Al-Olabi; Satyamaanasa Polubothu; Katherine Dowsett; Katrina A Andrews; Paulina Stadnik; Agnel P Joseph; Rachel Knox; Alan Pittman; Graeme Clark; William Baird; Neil Bulstrode; Mary Glover; Kristiana Gordon; Darren Hargrave; Susan M Huson; Thomas S Jacques; Gregory James; Hannah Kondolf; Loshan Kangesu; Kim M Keppler-Noreuil; Amjad Khan; Marjorie J Lindhurst; Mark Lipson; Sahar Mansour; Justine O'Hara; Caroline Mahon; Anda Mosica; Celia Moss; Aditi Murthy; Juling Ong; Victoria E Parker; Jean-Baptiste Rivière; Julie C Sapp; Neil J Sebire; Rahul Shah; Branavan Sivakumar; Anna Thomas; Alex Virasami; Regula Waelchli; Zhiqiang Zeng; Leslie G Biesecker; Alex Barnacle; Maya Topf; Robert K Semple; E Elizabeth Patton; Veronica A Kinsler
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

View more
  2 in total

1.  Somatic activating BRAF variants cause isolated lymphatic malformations.

Authors:  Kaitlyn Zenner; Dana M Jensen; Victoria Dmyterko; Giridhar M Shivaram; Candace T Myers; Cate R Paschal; Erin R Rudzinski; Minh-Hang M Pham; V Chi Cheng; Scott C Manning; Randall A Bly; Sheila Ganti; Jonathan A Perkins; James T Bennett
Journal:  HGG Adv       Date:  2022-03-15

Review 2.  Atlas of Nervous System Vascular Malformations: A Systematic Review.

Authors:  Carlos Castillo-Rangel; Gerardo Marín; Karla Aketzalli Hernandez-Contreras; Cristofer Zarate-Calderon; Micheel Merari Vichi-Ramirez; Wilmar Cortez-Saldias; Marco Antonio Rodriguez-Florido; Ámbar Elizabeth Riley-Moguel; Omar Pichardo; Osvaldo Torres-Pineda; Helena G Vega-Quesada; Ramiro Lopez-Elizalde; Jaime Ordoñez-Granja; Hugo Helec Alvarado-Martinez; Luis Andrés Vega-Quesada; Gonzalo Emiliano Aranda-Abreu
Journal:  Life (Basel)       Date:  2022-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.